These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7035326)

  • 1. Morphological identification of alpha-I-antitrypsin in the human small intestine.
    Geboes K; Ray MB; Rutgeerts P; Callea F; Desmet VJ; Vantrappen G
    Histopathology; 1982 Jan; 6(1):55-60. PubMed ID: 7035326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-1-antitrypsin immunoreactivity in the small bowel in coeliac disease.
    Malik AK; McGee JO
    Malays J Pathol; 1993 Dec; 15(2):151-4. PubMed ID: 8065178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of acyl-CoA synthetase 5 reflects the state of villus architecture in human small intestine.
    Gassler N; Kopitz J; Tehrani A; Ottenwälder B; Schnölzer M; Kartenbeck J; Lyer S; Autschbach F; Poustka A; Otto HF; Mollenhauer J
    J Pathol; 2004 Feb; 202(2):188-96. PubMed ID: 14743501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative differences in faecal alpha-1-antitrypsin in patients with Crohn's disease.
    Colombel JF; Mizon C; Balduyck M; Cortot A
    Gut; 1989 Feb; 30(2):279-80. PubMed ID: 2784776
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoreactivity of alpha-1-antitrypsin in the human colon.
    Geboes K; Rutgeerts P; Vantrappen G; Desmet VJ
    Hepatogastroenterology; 1983 Feb; 30(1):24-6. PubMed ID: 6339344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coeliac disease: alpha-1-antitrypsin contents in jejunal mucosa before and after gluten-free diet.
    Nielsen K
    Histopathology; 1984 Sep; 8(5):759-64. PubMed ID: 6335124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical demonstration of a1-Antitrypsin and a1-Antichymotrypsin in human gastrointestinal tract.
    Kittas C; Aroni K; Matani A; Papadimitriou CS
    Hepatogastroenterology; 1982 Dec; 29(6):275-7. PubMed ID: 6983995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease.
    Thomas DW; Sinatra FR; Merritt RJ
    J Pediatr Gastroenterol Nutr; 1983; 2(3):491-6. PubMed ID: 6604798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
    Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
    Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.
    Boege F; Fischbach W
    Gut; 1991 May; 32(5):496-9. PubMed ID: 2040471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lysozyme in inflammatory bowel and coeliac disease.
    Mallas E; Terry JM; Asquith P; Cooke WT
    J Clin Pathol; 1976 Jul; 29(7):598-600. PubMed ID: 977770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha 1-Antitrypsin-levels and phenotypes in Crohn's disease in the Netherlands.
    Klasen EC; Biemond I; Weterman IT
    Gut; 1980 Oct; 21(10):840-2. PubMed ID: 6969207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of fecal alpha 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease.
    Boirivant M; Pallone F; Ciaco A; Leoni M; Fais S; Torsoli A
    Dig Dis Sci; 1991 Mar; 36(3):347-52. PubMed ID: 1995272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coeliac disease is associated with impaired expression of acyl-CoA-synthetase 5.
    Obermüller N; Keith M; Kopitz J; Autschbach F; Schirmacher P; Gassler N
    Int J Colorectal Dis; 2006 Mar; 21(2):130-4. PubMed ID: 15809837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease.
    el Yamani J; Mizon C; Capon C; Colombel JF; Fournet B; Cortot A; Mizon J
    Clin Sci (Lond); 1992 Oct; 83(4):409-15. PubMed ID: 1330402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of group II phospholipase A2 in intestine in Crohn's disease.
    Haapamäki MM; Grönroos JM; Nurmi H; Alanen K; Nevalainen TJ
    Am J Gastroenterol; 1999 Mar; 94(3):713-20. PubMed ID: 10086656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescent detection of alpha1-antitrypsin in paraffin embedded liver tissue.
    Ray MB; Desmet VJ
    J Clin Pathol; 1975 Sep; 28(9):717-21. PubMed ID: 1100679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Crohn's disease activity and alpha 1-antitrypsin in faeces.
    Arndt B; Schürmann G; Betzler M; Herfarth C; Schmidt-Gayk H
    Lancet; 1992 Oct; 340(8826):1037. PubMed ID: 1357424
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantitative investigations of the structure and function of the intestinal mucosa in endoscopically obtained biopsy material. Findings in patients with coeliac disease, patients with partially resected small intestine in Crohn's disease and in patients with small intestine resection for other reasons (author's transl)].
    Lorenz-Meyer H; Ziegler K; Böger M; Adler G; Rohde H; Brandes W
    Z Gastroenterol; 1980 Dec; 18(12):605-16. PubMed ID: 7281851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.